DE68912376T2 - Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie. - Google Patents

Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.

Info

Publication number
DE68912376T2
DE68912376T2 DE68912376T DE68912376T DE68912376T2 DE 68912376 T2 DE68912376 T2 DE 68912376T2 DE 68912376 T DE68912376 T DE 68912376T DE 68912376 T DE68912376 T DE 68912376T DE 68912376 T2 DE68912376 T2 DE 68912376T2
Authority
DE
Germany
Prior art keywords
analogs
bradykinin
therapy
synthesis
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68912376T
Other languages
English (en)
Other versions
DE68912376D1 (de
Inventor
David H Coy
Jacques-Pierre Moreau
John E Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
Original Assignee
Tulane University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tulane University filed Critical Tulane University
Publication of DE68912376D1 publication Critical patent/DE68912376D1/de
Application granted granted Critical
Publication of DE68912376T2 publication Critical patent/DE68912376T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57572Gastrin releasing peptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • C07K14/685Alpha-melanotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE68912376T 1988-03-25 1989-03-28 Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie. Expired - Fee Related DE68912376T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17331188A 1988-03-25 1988-03-25

Publications (2)

Publication Number Publication Date
DE68912376D1 DE68912376D1 (de) 1994-03-03
DE68912376T2 true DE68912376T2 (de) 1994-07-07

Family

ID=22631443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68912376T Expired - Fee Related DE68912376T2 (de) 1988-03-25 1989-03-28 Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.

Country Status (7)

Country Link
EP (1) EP0334685B1 (de)
AT (1) ATE100465T1 (de)
AU (1) AU3428089A (de)
CA (1) CA1335622C (de)
DE (1) DE68912376T2 (de)
ES (1) ES2061977T3 (de)
WO (1) WO1989009230A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
CA2171446C (en) * 1993-09-09 2004-11-23 Donald James Kyle Pseudo- and non-peptide bradykinin receptor antagonists
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330857A (en) * 1963-07-01 1967-07-11 Pfizer & Co C N-carbazoylamino acid intermediates for polypeptides
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide

Also Published As

Publication number Publication date
ES2061977T3 (es) 1994-12-16
EP0334685A2 (de) 1989-09-27
EP0334685B1 (de) 1994-01-19
WO1989009230A1 (en) 1989-10-05
DE68912376D1 (de) 1994-03-03
ATE100465T1 (de) 1994-02-15
AU3428089A (en) 1989-10-16
CA1335622C (en) 1995-05-16
EP0334685A3 (de) 1991-01-30

Similar Documents

Publication Publication Date Title
NZ314207A (en) 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
PT891331E (pt) Derivados do acido n-(2-oxoacetil ou sulfonil)-pirrolidino/piperidina-2-carboxilico com actividade melhorada de resistencia a multifarmacos
EP0357030A3 (en) Use of thromboxane a2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
ATE100465T1 (de) Analoge von bradykinin, dessen synthese und dessen benutzung in der therapie.
DE68906707T2 (de) 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
DE58907381D1 (de) Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin.
DK412985A (da) Prolinforbindelse og farmaceutisk praeparat indeholdende forbindelsen
DE68922035D1 (de) Glyzerin-Derivat und dessen pharmazeutische Verwendung.
ATE30417T1 (de) N-substituierte 1-(4'-alkylthiophenyl)-2-amino1,3-propanediol-derivate.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
FI913645A0 (fi) Transdermalt system med vilket farmakologiskt aktiva foereningar appliseras i effekt-kontrollerade faorhaollanden.
ATE114310T1 (de) Alpha-adrenergische rezeptorantagonisten.
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
ATE109483T1 (de) Alpha-adrenergische rezeptorantagonisten.
SU1455624A1 (ru) 6,8-ДИМЕТИЛ-2-ПИПЕРИДИНОМЕТИЛ-2,3-ДИГИДРОТИАЗОЛО[2,3-f]КСАНТИНА ГИДРОХЛОРИД, ПРОЯВЛЯЮЩИЙ ГИПОТЕНЗИВНУЮ И ПРОТИВОАРИТМИЧЕСКУЮ АКТИВНОСТЬ
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.
TH13016EX (th) สารประกอบชนิดใหม่ซึ่งแสดงฤทธิ์ในการรักษาโรค

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee